The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study.
The Chikungunya epidemic on La Réunion Island in 2005-2006: a cost-of-illness study.
复制标题
DOI：
10.1371/journal.pntd.0001197
复制
发表时间：
2011-06
影响因子：
3.8
通讯作者：
Hanslik T
中科院分区：
文献类型：
--
作者：
Soumahoro MK;Boelle PY;Gaüzere BA;Atsou K;Pelat C;Lambert B;La Ruche G;Gastellu-Etchegorry M;Renault P;Sarazin M;Yazdanpanah Y;Flahault A;Malvy D;Hanslik T
这项研究是为了评估2005-2006年在留尼旺岛发生的基孔肯雅热流行病对卫生费用的影响。根据从卫生机构收集的数据，基孔肯雅病在咨询、药物消费和缺勤方面产生的额外费用是通过与流行病时期以外的预期费用进行比较来确定的。根据国家短期护理住院数据库提供的数据，通过考虑ICD-10代码A92.0出现的所有住院时间，估计住院费用。从第三方支付者的角度进行了一项疾病成本研究。对每例门诊和住院病例的直接医疗费用进行了评估。这些费用是按2006年的价值以欧元估算的。全科医生咨询和药物的额外补偿估计分别为1，240万欧元（范围：770万欧元至1，710万欧元）和500万欧元（190万欧元至810万欧元），而基孔肯雅病住院费用估计为850万欧元（580万欧元至870万欧元）。生产成本估计为1740万欧元（600万欧元至2890万欧元）。基孔肯雅热疫情的医疗成本估计为4390万欧元，其中60%是直接医疗成本，40%是间接成本（分别为2650万欧元和1740万欧元）。直接医疗费用估计为每名门诊病人90欧元，每名住院病人2 000欧元。基孔肯雅热在留尼汪岛流行期间的医疗管理带来了沉重的经济负担。报告疾病的估计成本可用于评估新出现虫媒病毒预防和控制方案的成本/效果和成本/效益比。长期以来，基孔肯雅病毒感染的研究一直被忽视，但自从它在印度洋西南部和留尼汪岛死灰复燃以来，这种疾病受到了更多的关注。基孔肯雅热流行病的经济和社会影响的记录很少，包括在发达国家。这项研究估计了与2005-2006年留尼汪岛基孔肯雅热流行病相关的疾病成本，留尼汪岛是法国的海外省，拥有发达国家的经济和卫生保健系统。“疾病成本”研究衡量的是在没有疾病的情况下本可以节省的金额。我们发现，疫情造成的医疗费用估计为4390万欧元，其中60%是直接医疗费用，特别是与医疗咨询（47%）、住院（32%）和药物（19%）有关的费用。门诊和住院病例的护理费用分别为90欧元和2000欧元。本研究为基孔肯雅病预防战略的成本效益和成本效益评估提供了基本投入。
This study was conducted to assess the impact of chikungunya on health costs during the epidemic that occurred on La Réunion in 2005–2006. From data collected from health agencies, the additional costs incurred by chikungunya in terms of consultations, drug consumption and absence from work were determined by a comparison with the expected costs outside the epidemic period. The cost of hospitalization was estimated from data provided by the national hospitalization database for short-term care by considering all hospital stays in which the ICD-10 code A92.0 appeared. A cost-of-illness study was conducted from the perspective of the third-party payer. Direct medical costs per outpatient and inpatient case were evaluated. The costs were estimated in Euros at 2006 values. Additional reimbursements for consultations with general practitioners and drugs were estimated as €12.4 million (range: €7.7 million–€17.1 million) and €5 million (€1.9 million–€8.1 million), respectively, while the cost of hospitalization for chikungunya was estimated to be €8.5 million (€5.8 million–€8.7 million). Productivity costs were estimated as €17.4 million (€6 million–€28.9 million). The medical cost of the chikungunya epidemic was estimated as €43.9 million, 60% due to direct medical costs and 40% to indirect costs (€26.5 million and €17.4 million, respectively). The direct medical cost was assessed as €90 for each outpatient and €2,000 for each inpatient. The medical management of chikungunya during the epidemic on La Réunion Island was associated with an important economic burden. The estimated cost of the reported disease can be used to evaluate the cost/efficacy and cost/benefit ratios for prevention and control programmes of emerging arboviruses. For a long time, studies of chikungunya virus infection have been neglected, but since its resurgence in the south-western Indian Ocean and on La Réunion Island, this disease has been paid greater amounts of attention. The economic and social impacts of chikungunya epidemics are poorly documented, including in developed countries. This study estimated the cost-of-illness associated with the 2005–2006 chikungunya epidemics on La Réunion Island, a French overseas department with an economy and health care system of a developed country. “Cost-of-illness” studies measure the amount that would have been saved in the absence of a disease. We found that the epidemic incurred substantial medical expenses estimated at €43.9 million, of which 60% were attributable to direct medical costs related, in particular, to expenditure on medical consultations (47%), hospitalization (32%) and drugs (19%). The costs related to care in ambulatory and hospitalized cases were €90 and €2000 per case, respectively. This study provides the basic inputs for conducting cost-effectiveness and cost-benefit evaluations of chikungunya prevention strategies.
登录
查看更多内容
影响因子：
8.8
作者：
Lemant, Jerome;Boisson, Veronique;Michault, Alain
通讯作者：
Michault, Alain
影响因子：
11.8
作者：
Borgherini, Gianandrea;Poubeau, Patrice;Paganin, Fabrice
通讯作者：
Paganin, Fabrice
影响因子：
11.8
作者：
Lewthwaite, Penny;Vasanthapuram, Ravi;Solomon, Tom
通讯作者：
Solomon, Tom
DOI：
10.1016/s0001-4079(19)33100-0
发表时间：
2007-01-01
影响因子：
0.3
作者：
Flahault, Antoine;Aumont, Gilles;Setbon, Michel
通讯作者：
Setbon, Michel
影响因子：
4.2
作者：
Economopoulou, A.;Dominguez, M.;Quatresous, I.
通讯作者：
Quatresous, I.